JP2005535342A5 - - Google Patents

Download PDF

Info

Publication number
JP2005535342A5
JP2005535342A5 JP2004529297A JP2004529297A JP2005535342A5 JP 2005535342 A5 JP2005535342 A5 JP 2005535342A5 JP 2004529297 A JP2004529297 A JP 2004529297A JP 2004529297 A JP2004529297 A JP 2004529297A JP 2005535342 A5 JP2005535342 A5 JP 2005535342A5
Authority
JP
Japan
Prior art keywords
nad
increase
flow
stress
pnc1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004529297A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005535342A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/025016 external-priority patent/WO2004016726A2/en
Publication of JP2005535342A publication Critical patent/JP2005535342A/ja
Publication of JP2005535342A5 publication Critical patent/JP2005535342A5/ja
Pending legal-status Critical Current

Links

JP2004529297A 2002-08-09 2003-08-08 細胞及び生物の寿命を延ばし、ストレス耐性を増す方法及び組成物 Pending JP2005535342A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40225402P 2002-08-09 2002-08-09
US42861402P 2002-11-22 2002-11-22
PCT/US2003/025016 WO2004016726A2 (en) 2002-08-09 2003-08-08 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010162637A Division JP2011015682A (ja) 2002-08-09 2010-07-20 細胞及び生物の寿命を延ばし、ストレス耐性を増す方法及び組成物

Publications (2)

Publication Number Publication Date
JP2005535342A JP2005535342A (ja) 2005-11-24
JP2005535342A5 true JP2005535342A5 (cg-RX-API-DMAC10.html) 2010-03-04

Family

ID=31720582

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2004529297A Pending JP2005535342A (ja) 2002-08-09 2003-08-08 細胞及び生物の寿命を延ばし、ストレス耐性を増す方法及び組成物
JP2010162637A Pending JP2011015682A (ja) 2002-08-09 2010-07-20 細胞及び生物の寿命を延ばし、ストレス耐性を増す方法及び組成物
JP2015117465A Expired - Fee Related JP6602561B2 (ja) 2002-08-09 2015-06-10 細胞及び生物の寿命を延ばし、ストレス耐性を増す方法及び組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010162637A Pending JP2011015682A (ja) 2002-08-09 2010-07-20 細胞及び生物の寿命を延ばし、ストレス耐性を増す方法及び組成物
JP2015117465A Expired - Fee Related JP6602561B2 (ja) 2002-08-09 2015-06-10 細胞及び生物の寿命を延ばし、ストレス耐性を増す方法及び組成物

Country Status (5)

Country Link
EP (2) EP1551964A4 (cg-RX-API-DMAC10.html)
JP (3) JP2005535342A (cg-RX-API-DMAC10.html)
AU (2) AU2003264037B2 (cg-RX-API-DMAC10.html)
CA (2) CA2421269A1 (cg-RX-API-DMAC10.html)
WO (1) WO2004016726A2 (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7977049B2 (en) 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US20060025337A1 (en) 2003-07-01 2006-02-02 President And Fellows Of Harvard College Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
US20050096256A1 (en) 2003-07-01 2005-05-05 President And Fellows Of Harvard College Compositions for manipulating the lifespan and stress response of cells and organisms
WO2006072809A2 (en) * 2003-10-31 2006-07-13 Robarts Research Institute Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
EP1708689A2 (en) 2003-12-29 2006-10-11 The President and Fellows of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
CN1964627B (zh) * 2004-06-04 2011-10-19 华盛顿大学 治疗神经病变的方法和组合物
SI1794306T1 (sl) 2004-09-24 2010-04-30 Bayer Bioscience Nv Rastline, odporne na stres
US20090012130A1 (en) * 2005-01-25 2009-01-08 The Johns Hopkins University Strategies for Designing Drugs that Target the Sir2 Family of Enzymes
EP2805719A1 (en) 2005-03-30 2014-11-26 Glaxosmithkline LLC Nicotinamide riboside and analogues thereof
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
ES2331022T3 (es) * 2005-06-15 2009-12-18 Bayer Bioscience N.V. Metodos para aumentar la resistencia de las plantas a condiciones hipoxicas.
KR20090007718A (ko) * 2006-03-21 2009-01-20 바이엘 바이오사이언스 엔.브이. 스트레스 저항성 식물
ES2513143T3 (es) 2006-12-11 2014-10-24 Japan Science And Technology Agency Regulador del crecimiento vegetal y sus usos
ES2647918T3 (es) * 2007-11-13 2017-12-27 Japan Science And Technology Agency Composición para la producción de cuerpos de plantas que tengan un contenido de azúcar mejorado y uso de la misma
JP5570731B2 (ja) * 2008-02-28 2014-08-13 旭化成ファーマ株式会社 ピロリン酸の測定方法
WO2009108999A1 (en) 2008-03-03 2009-09-11 Ross Stewart Grant Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders
JP2011115098A (ja) * 2009-12-04 2011-06-16 Nippon Menaade Keshohin Kk 加齢による皮膚明度の低下を予測する皮膚評価方法
KR101703180B1 (ko) 2011-12-12 2017-02-06 오카야마켄 식물의 아미노산 함량을 높이기 위한 화합물 및 그 이용
WO2014059034A2 (en) 2012-10-09 2014-04-17 President And Fellows Of Harvard College Nad biosynthesis and precursors for the treatment and prevention of cancer and proliferation
WO2015069860A1 (en) * 2013-11-06 2015-05-14 President And Fellows Of Harvard College Biological production of nad precursors and analogs
US10316054B2 (en) 2014-06-02 2019-06-11 Glaxosmithkline Intellectual Property (No. 2) Limited Preparation and use of crystalline beta-D-nicotinamide riboside
RU2016149767A (ru) 2014-06-06 2018-07-16 Глэксосмитклайн Интеллекчуал Проперти (Но.2) Лимитед Аналоги никотинамидрибозида и фармацевтические композиции и их применение
JP6623015B2 (ja) * 2014-09-29 2019-12-18 国立研究開発法人理化学研究所 植物の耐塩性向上剤
WO2020097116A1 (en) * 2018-11-05 2020-05-14 Rejuvenation Therapeutics Compositions and methods for culturing yeast cells
US20220324899A1 (en) * 2019-08-14 2022-10-13 Metro International Biotech, Llc Compounds and compositions for differential modulation of nicotinamide adenine dinucleotide
CN111394268B (zh) * 2019-12-20 2021-06-18 合肥康诺生物制药有限公司 基因工程菌及其构建方法、应用,生产nad+的方法
CN112451673A (zh) * 2020-12-10 2021-03-09 汤臣倍健股份有限公司 线粒体功能干预材料在制备改善线粒体功能的保健品或药品中的应用及其筛选方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
DE3681787D1 (de) 1985-07-05 1991-11-07 Whitehead Biomedical Inst Expression von fremdem genetischem material in epithelzellen.
HK1008049A1 (en) 1987-09-11 1999-04-30 Whitehead Institute For Biomedical Research Transduced fibroblasts and use therefor
ATE110108T1 (de) 1987-12-11 1994-09-15 Whitehead Biomedical Inst Genetische modifizierung von endothelialen zellen.
DE68927996T2 (de) 1988-02-05 1997-12-04 Hughes Howard Med Inst Modifizierte hepatozyten und deren anwendung
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
DE69123981T3 (de) 1990-10-31 2006-06-14 Cell Genesys Inc Nützliche retrovirale vektoren für die gentherapie
EP0650370A4 (en) 1992-06-08 1995-11-22 Univ California METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
WO1994006920A1 (en) 1992-09-22 1994-03-31 Medical Research Council Recombinant viruses displaying a nonviral polypeptide on their external surface
CA2148934C (en) 1992-11-09 2005-08-02 French W. Anderson Targetable vector particles
FR2705686B1 (fr) 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
CA2144040A1 (fr) 1993-07-13 1995-01-26 Michel Perricaudet Vecteurs adenoviraux defectifs et utilisation en therapie genique
US5631236A (en) 1993-08-26 1997-05-20 Baylor College Of Medicine Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
US5698443A (en) 1995-06-27 1997-12-16 Calydon, Inc. Tissue specific viral vectors
EP0784690B1 (en) 1994-06-10 2006-08-16 Genvec, Inc. Complementary adenoviral vector systems and cell lines
CA2203809C (en) 1994-10-28 2008-06-03 James M. Wilson Recombinant adenovirus and methods of use thereof
US5856152A (en) 1994-10-28 1999-01-05 The Trustees Of The University Of Pennsylvania Hybrid adenovirus-AAV vector and methods of use therefor
US5872005A (en) 1994-11-03 1999-02-16 Cell Genesys Inc. Packaging cell lines for adeno-associated viral vectors
CA2206683A1 (en) 1994-12-12 1996-06-20 Genetic Therapy, Inc. Improved adenoviral vectors and producer cells
DE69636863T2 (de) 1995-02-24 2007-11-15 Trustees Of The University Of Pennsylvania Benutzung von immunmodulatoren zur herstellung von medikamenten zur inhibierung einer immunantwort gegen gleichzeitig verabreichte rekombinante viren
US5688676A (en) 1995-06-07 1997-11-18 Research Foundation Of State University Of New York In vitro packaging of adeno-associated virus DNA
JPH11511326A (ja) 1995-08-30 1999-10-05 ジエンザイム コーポレイション アデノウィルスおよびaavの精製
GB9816781D0 (en) 1998-07-31 1998-09-30 Univ London Herpes virus vectors for dendritic cells
CN1478149A (zh) * 2000-10-03 2004-02-25 宝生物工程株式会社 生理活性物质的筛选方法
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
SI1794306T1 (sl) * 2004-09-24 2010-04-30 Bayer Bioscience Nv Rastline, odporne na stres
US9515947B1 (en) 2013-03-15 2016-12-06 EMC IP Holding Company LLC Method and system for providing a virtual network-aware storage array
KR20160071054A (ko) 2014-12-11 2016-06-21 에스케이하이닉스 주식회사 반도체 메모리 장치 및 그의 동작 방법
US9609948B2 (en) 2015-04-28 2017-04-04 Qianglong Furniture Co., Ltd. Rotating armrest apparatus

Similar Documents

Publication Publication Date Title
WO2007014127A3 (en) Fuel cell system with partial recycling of anode exhaust
CA2428959A1 (en) Fuel cell stack structure
EP0999605A3 (en) Fuel cell stack
AU2003263796A1 (en) Pem fuel cell stack without gas diffusion media
CL2008001865A1 (es) Método para identificar una muestra de germoplasma vegetal con un genotipo que modula el rendimiento de una caracteristica, y célula vegetal que contiene al menos una región genómatica identificada para modular el rendiemiento de transgenes.
Monard et al. Relationship between bacterial diversity and function under biotic control: the soil pesticide degraders as a case study
AU2003304194A1 (en) Fuel cell electrode comprising carbon nanotubes
JP2002535008A5 (cg-RX-API-DMAC10.html)
JP2007506790A5 (cg-RX-API-DMAC10.html)
PE20020172A1 (es) Metodo para producir una sustancia que utiliza un microrganismo
ATE403238T1 (de) Brennstoffzellen-gasseparator
WO2005060029A3 (en) Fuel cell and fuel cell stack
JP2009521795A5 (cg-RX-API-DMAC10.html)
JP2005226007A5 (cg-RX-API-DMAC10.html)
Maarof et al. Enhancing PV/T efficiency using PCM-integrated single-finned tube cooling system
AU2003219561A8 (en) Fuel cell electrode employing porous graphite film, membrane-electrode assembly and fuel cell
WO2005103566A3 (en) Online bakeout of regenerative oxidizers
TW200721579A (en) Electrode catalyst with improved longevity properties and fuel cell using the same
EP1253655A4 (en) FUEL CELL
NO20040656L (no) Modulaert innfagninskammer for flyktige organiske forbindelser (VOC) for en regenerativ oksidator med to kamre.
PE20010017A1 (es) Metodo para producir xilitol
JP2005529469A5 (cg-RX-API-DMAC10.html)
林讚標 et al. Low genetic diversity of Cycas taitungensis (Cycadaceae), an endemic species in Taiwan, revealed by allozyme analysis
JP2005149977A (ja) Nas電池電力貯蔵システム
JP2005054170A5 (cg-RX-API-DMAC10.html)